Medications for Endometriosis

4 results
AbbVie Inc.
Usage: LUPRON DEPOT 11.25 mg is indicated for managing endometriosis (pain relief and lesion reduction) and, when combined with norethindrone acetate, for symptom management. It also prepares women with anemia due to uterine fibroids for surgery, enhancing hematologic improvement alongside iron therapy. Total therapy duration should not exceed 12 months.

Myfembree (relugolix, estradiol hemihydrate, and norethindrone acetate)

(relugolix, estradiol hemihydrate, and norethindrone acetate)
Sumitomo Pharma America, Inc
Usage: MYFEMBREE is indicated for managing heavy menstrual bleeding associated with uterine leiomyomas and moderate to severe pain related to endometriosis in premenopausal women. Use should be limited to 24 months due to potential irreversible bone loss.

Orilissa

(Elagolix)
AbbVie Inc.
Usage: ORILISSA is indicated for managing moderate to severe pain associated with endometriosis. Use duration should be limited based on dosage and coexisting conditions.
TerSera Therapeutics LLC
Usage: ZOLADEX is indicated for managing Stage B2-C prostatic carcinoma in combination with flutamide, palliative treatment of advanced prostatic cancer, endometriosis management, endometrial thinning before ablation for dysfunctional bleeding, and palliative treatment of advanced breast cancer in pre- and perimenopausal women.